TITLE:
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

CONDITION:
Candidiasis

INTERVENTION:
Anidulafungin, VER002

SUMMARY:

      Anidulafungin may be effective for the treatment of invasive Candida infections. The purpose
      of the study is to find the balance between dose tolerance and effectiveness of several
      doses for the treatment of United States patients with invasive candidiasis.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Positive culture plus at least one clinical sign and symptom consistent with invasive
             candidiasis preferably within 96 hours of the proposed first dose of study drug

          -  Life expectancy: greater than 72 hours

        Exclusion Criteria:

          -  Pregnant Females

          -  Treatment with other investigational drug(s) within 4 weeks

          -  Hypersensitivity to anidulafungin or echinocandin therapy

          -  Hypersensitivity to Tween 80 (polysorbate 80) or tartaric acid
      
